#### ![calendar-Icon](/themes/custom/cosmos/patterns/images/calendar-v2.svg)February 02, 2022

 

 #### Basel, Switzerland

 

 

Novartis announces the company’s fourth quarter and 2021 full year financial results.

 

 

 [    Media Releases  (342 KB)   ](https://prod1.novartis.com/sites/novartis_com/files/q4-2021-media-release-en.pdf) [    Medienmitteilung  (310 KB)   ](https://prod1.novartis.com/sites/novartis_com/files/q4-2021-media-release-de.pdf) [    Communiqué de presse  (315 KB)   ](https://prod1.novartis.com/sites/novartis_com/files/q4-2021-media-release-fr.pdf) 

 



 [    Interim financial report  (499 KB)   ](https://prod1.novartis.com/sites/novartis_com/files/2022-02-interim-financial-report-en.pdf) 

 



## Webcast and presentation

[Read the transcript](/investors/financial-data/quarterly-results/2021-q4-and-full-year-results-transcript "2021 Q4 and full year results presentation and transcript")



[Download the investor presentation (PDF 4.9 MB)](/sites/novartis_com/files/q4-2021-investor-presentation.pdf)







---

## Annual Reporting 2021

### Annual Report 2021

This report, filed with the SIX Swiss Exchange in Switzerland, provides a comprehensive overview of Novartis, including our company structure, corporate governance and compensation practices. It also contains our operating and financial results, accompanied by audited annual financial statements.

[View the Novartis Annual Report 2021 (PDF 3.4 MB)](/sites/novartis_com/files/novartis-annual-report-2021.pdf)



### Novartis in Society Integrated Report 2021

The Novartis in Society Integrated Report covers our business, strategy and performance. It highlights progress against our five strategic priorities and describes how we create value for diverse stakeholders.

[View the report in English (PDF 7.7 MB)](/sites/novartis_com/files/novartis-integrated-report-2021-de.pdf "novartis-integrated-report-2021-de.pdf")







[Access a digital and interactive version on the Annual Reporting microsit](https://www.reporting.novartis.com/)

---

## Financial Results on Social Media

> “We’re building leadership positions in the platforms of the future to reimagine medicine for patients and lead this new era in health."  
>   
> \- Vas Narasimhan discussing how Novartis continues to grow with a pipeline of long-term innovation.[$NVS](https://twitter.com/search?q=%24NVS&src=ctag&ref_src=twsrc%5Etfw) [$NOVN](https://twitter.com/search?q=%24NOVN&src=ctag&ref_src=twsrc%5Etfw) [\#NVSQ421](https://twitter.com/hashtag/NVSQ421?src=hash&ref_src=twsrc%5Etfw)
> 
> — Novartis (@Novartis) [February 2, 2022](https://twitter.com/Novartis/status/1488784255048044546?ref_src=twsrc%5Etfw)



 



 [ 

 

###  Novartis Pipeline 

Benefiting from our continued focus on innovation, Novartis has one of the industry’s most competitive pipelines.

 

 

 ](https://www.novartis.com/research-development/novartis-pipeline) [ 

 

###  Executive Committee of Novartis (ECN) biographies 

Under the leadership of Vasant Narasimhan, the Executive Committee of Novartis (ECN) is responsible for overseeing the business operations of Group companies.

 

 

 ](/about/executive-committee) 





 

 [Download the Novartis Pipeline as of December 31, 2023 (PDF 0.1 MB)](/sites/novartis_com/files/novartis-pipeline-2023-annual-report.pdf "Download the Novartis Pipeline as of December 31, 2023 (PDF 0.1 MB)")